NativeSkin^® & Pharma

Discover NativeSkin^®, an advanced ex vivo human skin model designed to provide a physiologically relevant, cruelty-free platform for pharmaceutical research. This patented model preserves the structure, cellular complexity, and barrier function of real human skin, enabling reliable assessments of drug efficacy (e.g., transdermal delivery, topical activity, anti-inflammatory effects) and safety (e.g., local toxicity, irritation, immune response). With standardized and reproducible results, NativeSkin^® supports regulatory compliance, de-risks early development, and accelerates the translation of innovative therapies to the clinic.

The application note showcases the unique features of NativeSkin^®.

Learn the benefits of NativeSkin^® for pharma applications:

• • Skin delivery studies
  • Topical absorption and penetration studies
  • Effects on skin metabolism
  • Local toxicity
  • Effects on skin barrier function
  • Inflammation studies
  • Adverse effects assessment and safety studies
  • Skin microbiome interaction studies

You’ll also get access to exclusive data from case studies involving mRNA vaccine delivery, diagnostic microneedle patches, and non-steroidal anti-inflammatory drugs.

Download the application note to explore how NativeSkin^® supports ethical, human-relevant, and translational research for pharma.